Structure Therapeutics Inc.Structure Therapeutics Inc.Structure Therapeutics Inc.

Structure Therapeutics Inc.

No trades
No trades

Compare with Structure Therapeutics Inc.


Market capitalization
‪2.94 B‬USD
−3.08USD
‪−141.58 M‬USD
0.00USD
‪69.46 M‬
Beta (1Y)
0.39
Next report date
Report period
EPS estimate
Revenue estimate

Company info


CEO
Raymond C. Stevens
Headquarters
South San Francisco
Founded
2016
IPO date
Feb 3, 2023
ISIN
US86366E1064
CUSIP
86366E106
FIGI
BBG01CBVHLW1
Identifiers
ISIN US86366E1064
Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Weight0.17%
Market value‪17.59 M‬
Weight1.65%
Market value‪3.87 M‬
Weight0.81%
Market value‪3.32 M‬
Weight0.21%
Market value‪2.60 M‬
Weight0.21%
Market value‪2.60 M‬
Weight0.15%
Market value‪2.26 M‬
Weight2.36%
Market value‪1.42 M‬
Weight0.20%
Market value‪1.39 M‬
Weight3.34%
Market value‪1.31 M‬
Weight0.21%
Market value‪1.02 M‬
Weight0.95%
Market value‪960.21 K‬

Explore more ETFs